D-1332-2015 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- August 26, 2015
- Initiation Date
- March 23, 2015
- Termination Date
- May 20, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 35,197 vials; b) 21,302 vials
Product Description
Gemcitabine for Injection, USP, 200 mg*/vial, Lyophilized powder in a Single-Use Vial, Rx only, labeled as a) Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-464-20, UPC 3 67457 46420 6; and b) Distributed by Pfizer Labs, Division of Pfizer Inc, New York, NY 10017, Made in India, NDC 0069-3857-10, UPC 3 00693 85710 4.
Reason for Recall
Presence of Particulate Matter
Distribution Pattern
Nationwide and Puerto Rico
Code Information
Lot #: a) 7801396, 7801398, 7801401, 7801406, Exp 08/16; 7801427, Exp 09/16; b) 7801089, 7801084, Exp 07/15; 7801110, Exp 08/15